Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation
- PMID: 9635717
- DOI: 10.1016/s0360-3016(98)00077-7
Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation
Abstract
Purpose: Advances in bone marrow transplantation (BMT) have consistently improved long-term survival. Therefore, evaluation of late complications such as cataracts is of paramount importance.
Methods and materials: We analyzed data of 2149 patients from the EBMT registry. A cohort of 1063 patients were evaluable for survival and ophthalmologic status after transplant for acute leukemia (AL) in first or second complete remission. Conditioning therapy included either single-dose total body irradiation (STBI) or fractionated TBI (FTBI) grouped in different dose rates (low: LDR < or = 0.04 Gy/min; high: HDR > 0.04 Gy/min).
Results: The overall 10-year estimated cataract incidence (ECI) was 50%. It was 60% in the STBI group, 43% in the FTBI group < or = 6 fractions, and 7% in the FTBI group > 6 fractions (p < 10(-4)). It was significantly lower (30%) in the LDR than in the HDR groups (59%;p < 10(-4)). Patients receiving heparin for veno-occlusive disease prophylaxis had fewer cataracts than those who did not (10-year ECI: 33% vs. 53%, respectively;p = 0.04). The 10-year ECI was 65% in the allogeneic vs. 46% in the autologous BMT patients (p = 0.0018). Factors independently associated with an increased risk of cataract were an older age (> 23 years), higher dose rate (> 0.04 Gy/min), allogeneic BMT, and steroid administration (> 100 days). The use of FTBI was associated with a decreased risk of cataract. Heparin administration was a protective factor in patients receiving STBI. In terms of cataract surgery, the unfavorable factors for requiring surgery were: age > 23 yr, STBI, dose rate > 0.04 Gy/min, chronic graft-vs.-host disease (cGvHD), and absence of heparin administration. Among the patients who required cataract surgery (111 out of 257), secondary posterior capsular opacification was observed in 15.7%.
Conclusion: High dose rate and STBI are the main risk factors for cataract development and the need for surgery, and the administration of heparin has a protective role in cataractogenesis.
Similar articles
-
Cataractogenesis after total body irradiation.Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):53-60. doi: 10.1016/s0360-3016(96)85011-5. Int J Radiat Oncol Biol Phys. 1996. PMID: 8641927
-
Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.Strahlenther Onkol. 1998 Feb;174(2):92-104. doi: 10.1007/BF03038482. Strahlenther Onkol. 1998. PMID: 9487372 Free PMC article. Clinical Trial.
-
Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.Int J Radiat Oncol Biol Phys. 1996 Jan 1;34(1):71-7. doi: 10.1016/0360-3016(95)02063-2. Int J Radiat Oncol Biol Phys. 1996. PMID: 12118567
-
[Total body irradiation: techniques, dosimetry, and complications].Cancer Radiother. 1999 Mar-Apr;3(2):162-73. doi: 10.1016/s1278-3218(99)80047-x. Cancer Radiother. 1999. PMID: 10230376 Review. French.
-
[Radiation-induced cataract: physiopathologic, radiobiologic and clinical aspects].Cancer Radiother. 2001 Aug;5(4):397-412. doi: 10.1016/s1278-3218(01)00111-1. Cancer Radiother. 2001. PMID: 11525197 Review. French.
Cited by
-
Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation.Int J Hematol. 2002 Aug;76 Suppl 2:15-28. doi: 10.1007/BF03165081. Int J Hematol. 2002. PMID: 12430895 Review.
-
Late Effects After Haematopoietic Stem Cell Transplantation in ALL, Long-Term Follow-Up and Transition: A Step Into Adult Life.Front Pediatr. 2021 Nov 24;9:773895. doi: 10.3389/fped.2021.773895. eCollection 2021. Front Pediatr. 2021. PMID: 34900873 Free PMC article. Review.
-
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.Bone Marrow Transplant. 2019 May;54(5):648-661. doi: 10.1038/s41409-018-0339-6. Epub 2019 Feb 27. Bone Marrow Transplant. 2019. PMID: 30531955 Free PMC article.
-
Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease.Graefes Arch Clin Exp Ophthalmol. 2015 Jun;253(6):901-7. doi: 10.1007/s00417-015-2940-3. Epub 2015 Jan 27. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25619668 Free PMC article.
-
Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach.J Blood Med. 2020 May 15;11:141-162. doi: 10.2147/JBM.S206027. eCollection 2020. J Blood Med. 2020. PMID: 32523389 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical